N/A
Completed N=47
Effect of Banning Menthol Flavorant on Cigarette and E-Cigarette Use
Source: ClinicalTrials.gov NCT03402243 ↗Enrolled (actual)
47
Serious AEs
0.0%
Results posted
Aug 2021
Primary outcomePrimary: Amount of Tobacco Product Used — 13.1; 18.6; 15.3; 56.7 tobacco products use per day — p=0.349
Summary
In this pilot study, menthol cigarette smokers will be randomized to one of three experimental marketplaces: 1) a condition simulating a ban on menthol cigarettes but not menthol e-cigarettes (condition A); 2) a condition simulating a ban on both menthol cigarettes and menthol e-cigarettes (Condition B); and 3) a condition in which menthol is not banned for either product (Condition C - the control condition). All conditions would have medicinal nicotine available if subjects decide to quit tobacco products entirely. At visits occurring every two weeks over a 6 week period, subjects will receive "credits" that they could exchange for any product available in their randomized marketplace condition. Outcomes include the amount of each tobacco product used.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Amount of Tobacco Product Used |
13.1; 18.6; 15.3; 56.7; 10.7; 4.5 | 0.349 |
| SECONDARY How Much of Each Product is Obtained From the "Experimental Marketplace" |
22.6; 29.3; 28.8; 3.13; 1.2; 1.06 | 0.185 |
| SECONDARY Motivation to Quit Smoking Cigarettes |
3.6; 3.1; 3.2 | 0.27 |
Eligibility Criteria
Inclusion Criteria
- Be between the ages of 18 and 64
- Purchase exclusively menthol cigarettes
- Not currently motivated to quit smoking
- Smoking a minimum number of cigarettes per day
Exclusion Criteria
- Report a serious, unstable medical or psychiatric condition
- Use any medications that might interfere with measures to be studied (for example, medications known to affect smoking)
- Have used any smoking cessation therapy during the past month
- Regularly use any form of tobacco other than cigarettes
- Are pregnant or breast feeding or planning to become pregnant or breast feed during the study
Data sourced from ClinicalTrials.gov (NCT03402243). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.